| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |